Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Cough, Cold and Allergy (Hay Fever) Remedies in Russia

Published by: Euromonitor International

Published: Sep. 1, 2008 - 54 Pages


Table of Contents


OTC HEALTHCARE IN RUSSIA
Executive Summary
Dlo Crises Causes Stagnation in the Russian Pharmaceutical Market
New Registration Rules Lead To Cuts in Imports
Generics Continues To Be Predominant in Russia
Domestic Pharmaceutical Giant Among the Market Leaders
Opportunities for Growth
Key Trends and Developments
Lifestyles Improve, Although Life Expectancy Remains Low
Self-medication
Growth Enabled by Many Mergers and Acquisitions
Private Label Gains Ground
Retailer Chains Record Intensive and Extensive Growth
City Key Trends and Developments
Moscow
St Petersburg
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
Table 2 Life Expectancy at Birth 2002-2007
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
Table 5 Sales of OTC Healthcare by City: Value 2002-2007
Table 6 Sales of OTC Healthcare by City: % Value Growth 2002-2007
Table 7 OTC Healthcare Company Shares by Value 2003-2007
Table 8 OTC Healthcare Brand Shares by Value 2004-2007
Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
Table 13 Forecast Sales of OTC Healthcare by City: Value 2007-2012
Table 14 Forecast Sales of OTC Healthcare by City: % Value Growth 2007-2012
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Vitamins and Dietary Supplements Registration and Classification
Generics
Switches
Summary 1 OTC Healthcare Switches 2007
Definitions
Summary 2 Research Sources
LOCAL COMPANY PROFILES - RUSSIA
Akrikhin Oao
Strategic Direction
Key Facts
Summary 3 Akrikhin OAO: Key Facts
Summary 4 Akrikhin OAO: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Akrikhin OAO: Competitive Position 2007
Berlin Chemie Russia
Strategic Direction
Key Facts
Summary 6 Berlin Chemie/ Menarini Group: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Berlin Chemie/Menarini group : Competitive Position 2007
GlaxoSmithKline Plc
Strategic Direction
Key Facts
Summary 8 GlaxoSmithKline PLC: Key Facts
Company Background
Production
Competitive Positioning
Summary 9 GlaxoSmithKline PLC: Competitive Position 2007
Novartis AG
Strategic Direction
Key Facts
Summary 10 Novartis AG : Key Facts
Summary 11 Novartis AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Novartis AG: Competitive Position 2007
Otechestvennye Lekarstva Oao
Strategic Direction
Key Facts
Summary 13 Otechestvennye Lekarstva Holding: Key Facts
Summary 14 Otechestvennye Lekarstva Holding: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Otechestvennye Lekarstva Holding: Competitive Position 2007
Pharmstandard Group
Strategic Direction
Key Facts
Summary 16 Pharmstandard Group: Key Facts
Summary 17 Pharmstandard Group: Operational Indicators
Company Background
Production
Summary 18 Pahrmstandard Group : Production Statistics 2007
Competitive Positioning
Summary 19 Pharmstandard: Competitive Position 2007
Ranbaxy Laboratories Ltd
Strategic Direction
Key Facts
Summary 20 Ranbaxy Laboratories limited: Key Facts
Summary 21 Ranbaxy Laboratories limited: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 22 Ranbaxy ZAO: Competitive Position 2007
Sanofi-aventis
Strategic Direction
Key Facts
Summary 23 Sanofi-Aventis: Key Facts
Summary 24 Sanofi-Aventis: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 25 Sanofi-Aventis: Competitive Position 2007
Stada Arzneimittel AG
Strategic Direction
Key Facts
Summary 26 Stada Arzneimittel AG: Key Facts
Summary 27 Stada Arzneimittel AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 28 Stada Arzneimittel AG: Competitive Position 2007
Veropharm Zao
Strategic Direction
Key Facts
Summary 29 Veropharm OAO: Key Facts
Summary 30 Veropharm OAO: Operational Indicators
Company Background
Production
Summary 31 Veropharm OAO: Production Statistics 2006
Competitive Positioning
Summary 32 Veropharm OAO: Competitive Position 2007
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN RUSSIA
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 15 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2002-2007
Table 16 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2002-2007
Table 17 Sales of Decongestants by Type: Value 2002-2007
Table 18 Sales of Decongestants by Type: % Value Growth 2002-2007
Table 19 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2002-2007
Table 20 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2002-2007
Table 21 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2002-2007
Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2003-2007
Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2004-2007
Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2007-2012
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2007-2012

Abstract

Euromonitor International's Cough, Cold and Allergy Products in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2002-2007), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2012 illustrate how the market is set to change.

Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
  • Get a detailed picture of the cough, cold and allergy (hayfever) industry
  • Identify factors driving change
  • Understand the competitive environment, the market’s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai and Cape Town and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009